PDMR Notification RSU Vesting
PureTech Health plc announced that 33% of restricted share units granted to directors and PDMRs on November 19, 2025, vested on August 1, 2026, and were issued on August 17, 2026. The market price used for calculation was 121.13 pence per share. Following the issuance, the company's total issued ordinary share capital is 257,927,489 shares. Eric Elenko received 98,132 shares, Charles Sherwood received 41,100 shares, and Michael Inbar received 20,019 shares, totaling 159,251 shares issued to these individuals.
Select text to share a quote on X · sign in to keep highlights & notes in your PRTC notes
PDMR Notifications
PureTech Health plc (LSE: PRTC) ("PureTech" or the "Company") a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, announces that 33% of the shares subject to awards of restricted share units ("RSUs") granted by PureTech on 19 November 2025 to certain directors and other persons discharging managerial responsibilities ("PDMRs") pursuant to its Performance Share Plan ("PSP") vested on 01 August 2026 and were subsequently issued to the PDMRs noted below.
Each PDMR received vested ordinary shares (after deduction of shares for payroll taxes) on 17 August 2026. The market price per ordinary share in the Company used to calculate the amount payable to the PDMRs and the amount of shares to be issued to PDMRs was 121.13 pence, being the average closing price of the Company's shares over the three-trading day period immediately prior to issuance, and the exchange rate used to calculate the cash payment and amount of share settlement was £1: $1.35.
PDMR Notification
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Eric Elenko Charles Sherwood Michael Inbar |
| 2 | Reason for the notification | |
| a) | Position/status | Eric Elenko - President Charles Sherwood - Chief Operating Officer, General Counsel, and Corporate Secretary Michael Inbar - Chief Accounting Officer |
| b) | Initial notification/Amendment | Initial Notification |
| a) | Name | PureTech Health plc |
| b) | LEI | 213800LVPDNO2Z9T9I39 |
| c) | Price(s) and volume(s) | Recipient Price Amount Eric Elenko 0.01 GBP 98,132 ordinary shares Charles Sherwood 0.01 GBP 41,100 ordinary shares Michael Inbar 0.01 GBP 20,019 ordinary shares |
| e) | Date of the transaction | 17 August 2026 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.